Zobrazeno 1 - 10
of 47
pro vyhledávání: '"Ian, Mckeith"'
Autor:
Federico Rodriguez-Porcel, Kathryn A. Wyman-Chick, Carla Abdelnour Ruiz, Jon B. Toledo, Daniel Ferreira, Prabitha Urwyler, Rimona S. Weil, Joseph Kane, Andrea Pilotto, Arvid Rongve, Bradley Boeve, John-Paul Taylor, Ian McKeith, Dag Aarsland, Simon J. G. Lewis, the Lewy Body Dementias Clinical Trials Workgroup from the Lewy Body Dementias Professional Interest Area - Alzheimer’s Association International Society to Advance Alzheimer’s Research and Treatment (ISTAART)
Publikováno v:
Translational Neurodegeneration, Vol 11, Iss 1, Pp 1-18 (2022)
Abstract The selection of appropriate outcome measures is fundamental to the design of any successful clinical trial. Although dementia with Lewy bodies (DLB) is one of the most common neurodegenerative conditions, assessment of therapeutic benefit i
Externí odkaz:
https://doaj.org/article/6058a154f53c4fd0b938c4c0b34ec507
Autor:
James Gratwicke, Ludvic Zrinzo, Joshua Kahan, Amy Peters, Una Brechany, Ann McNichol, Mazda Beigi, Harith Akram, Jonathan Hyam, Ashwini Oswal, Brian Day, Laura Mancini, John Thornton, Tarek Yousry, Sebastian J. Crutch, John-Paul Taylor, Ian McKeith, Lynn Rochester, Jonathan M. Schott, Patricia Limousin, David Burn, Martin N. Rossor, Marwan Hariz, Marjan Jahanshahi, Thomas Foltynie
Publikováno v:
Brain Stimulation, Vol 13, Iss 4, Pp 1031-1039 (2020)
Background: Dementia with Lewy bodies (DLB) is the second most common form of dementia. Current symptomatic treatment with medications remains inadequate. Deep brain stimulation of the nucleus basalis of Meynert (NBM DBS) has been proposed as a poten
Externí odkaz:
https://doaj.org/article/6244cd495bf54274b6a34fbd4e88577b
Autor:
John T O’Brien, John-Paul Taylor, Alan Thomas, Claire Bamford, Luke Vale, Sarah Hill, Louise Allan, Tracy Finch, Richard McNally, Louise Hayes, Ajenthan Surendranathan, Joseph Kane, Alexandros E Chrysos, Allison Bentley, Sally Barker, James Mason, David Burn, Ian McKeith
Publikováno v:
Programme Grants for Applied Research, Vol 9, Iss 7 (2021)
Background: Lewy body dementia, comprising both dementia with Lewy bodies and Parkinson’s disease dementia, is the second commonest cause of neurodegenerative dementia. Existing evidence suggests that it is underdiagnosed and without a consistent a
Externí odkaz:
https://doaj.org/article/babfa2016f3142709c81cde594a967e9
Autor:
Tiago Fleming Outeiro, David J. Koss, Daniel Erskine, Lauren Walker, Marzena Kurzawa-Akanbi, David Burn, Paul Donaghy, Christopher Morris, John-Paul Taylor, Alan Thomas, Johannes Attems, Ian McKeith
Publikováno v:
Molecular Neurodegeneration, Vol 14, Iss 1, Pp 1-18 (2019)
Abstract Dementia with Lewy bodies (DLB) is an age-associated neurodegenerative disorder producing progressive cognitive decline that interferes with normal life and daily activities. Neuropathologically, DLB is characterised by the accumulation of a
Externí odkaz:
https://doaj.org/article/ee05c131d9894b98a2318875d6b68045
Autor:
Federico Rodriguez-Porcel, Kathryn A. Wyman-Chick, Carla Abdelnour Ruiz, Jon B. Toledo, Daniel Ferreira, Prabitha Urwyler, Rimona S. Weil, Joseph Kane, Andrea Pilotto, Arvid Rongve, Bradley Boeve, John-Paul Taylor, Ian McKeith, Dag Aarsland, Simon J. G. Lewis, the Lewy Body Dementias Clinical Trials Workgroup from the Lewy Body Dementias Professional Interest Area - Alzheimer’s Association International Society to Advance Alzheimer’s Research and Treatment (ISTAART)
Publikováno v:
Translational Neurodegeneration, Vol 11, Iss 1, Pp 1-1 (2022)
Externí odkaz:
https://doaj.org/article/35c0f8e869484f1cb49f4fb1335b03d4
Autor:
Tiago F. Outeiro, Roy N. Alcalay, Angelo Antonini, Johannes Attems, Vincenzo Bonifati, Francisco Cardoso, Marie‐Françoise Chesselet, John Hardy, Graziella Madeo, Ian McKeith, Brit Mollenhauer, Darren J. Moore, Olivier Rascol, Michael G. Schlossmacher, Hermona Soreq, Leonidas Stefanis, Joaquim J. Ferreira
Publikováno v:
Movement Disorders.
© 2023 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society. This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs L
Autor:
Simona S. Ghanem, Nour K. Majbour, Nishant N. Vaikath, Mustafa T. Ardah, Daniel Erskine, Nanna Møller Jensen, Muneera Fayyad, Indulekha P. Sudhakaran, Eftychia Vasili, Katerina Melachroinou, Ilham Y. Abdi, Ilaria Poggiolini, Patricia Santos, Anton Dorn, Paolo Carloni, Kostas Vekrellis, Johannes Attems, Ian McKeith, Tiago F. Outeiro, Poul Henning Jensen, Omar M. A. El-Agnaf
Publikováno v:
Ghanem, S S, Majbour, N K, Vaikath, N N, Ardah, M T, Erskine, D, Jensen, N M, Fayyad, M, Sudhakaran, I P, Vasili, E, Melachroinou, K, Abdi, I Y, Poggiolini, I, Santos, P, Dorn, A, Carloni, P, Vekrellis, K, Attems, J, McKeith, I, Outeiro, T F, Jensen, P H & El-Agnaf, O M A 2022, ' α-Synuclein phosphorylation at serine 129 occurs after initial protein deposition and inhibits seeded fibril formation and toxicity ', PNAS (Proceedings of the National Academy of Sciences of the United States of America), vol. 119, no. 15, e2109617119 . https://doi.org/10.1073/pnas.2109617119
Proceedings of the National Academy of Sciences of the United States of America 119(15), e2109617119 (2022). doi:10.1073/pnas.2109617119
Proceedings of the National Academy of Sciences of the United States of America 119(15), e2109617119 (2022). doi:10.1073/pnas.2109617119
α-Synuclein (α-syn) phosphorylation at serine 129 (pS129–α-syn) is substantially increased in Lewy body disease, such as Parkinson’s disease (PD) and dementia with Lewy bodies (DLB). However, the pathogenic relevance of pS129–α-syn remains
Autor:
Claudio Babiloni, Ivan Lorenzo, Roberta Lizio, Susanna Lopez, Federico Tucci, Raffaele Ferri, Andrea Soricelli, Flavio Nobili, Dario Arnaldi, Francesco Famà, Carla Buttinelli, Franco Giubilei, Virginia Cipollini, Marco Onofrj, Fabrizio Stocchi, Laura Vacca, Peter Fuhr, Ute Gschwandtner, Gerhard Ransmayr, Dag Aarsland, Lucilla Parnetti, Moira Marizzoni, Fabrizia D'Antonio, Carlo De Lena, Bahar Güntekin, Ebru Yıldırım, Lutfu Hanoğlu, Görsev Yener, Duygu Hünerli Gündüz, John Paul Taylor, Julia Schumacher, Ian McKeith, Giovanni B. Frisoni, Maria Francesca De Pandis, Laura Bonanni, Claudio Del Percio, Giuseppe Noce
Please modify the Abstract as follows:Here we tested if the reactivity of posterior resting-state electroencephalographic (rsEEG) alpha rhythms from the eye-closed to the eyes-open condition may differ in patients with dementia due to Lewy Bodies (DL
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4f1517cd8f61f66313082b7cc6b21454
http://hdl.handle.net/11391/1530857
http://hdl.handle.net/11391/1530857
Autor:
Claudio Babiloni, Giuseppe Noce, Federico Tucci, Raffaele Ferri, Simonetta Panerai, Valentina Catania, Andrea Soricelli, Marco Salvatore, Flavio Nobili, Dario Arnaldi, Francesco Famà, Carla Buttinelli, Franco Giubilei, Marco Onofrj, Fabrizio Stocchi, Laura Vacca, Fabiana Radicati, Peter Fuhr, Ute Gschwandtner, Gerhard Ransmayr, Lucilla Parnetti, Moira Marizzoni, Fabrizia D'Antonio, Giuseppe Bruno, Carlo De Lena, Bahar Güntekin, Ebru Yıldırım, Luftu Hanoglu, Görsev Yener, Duygu Hünerli Gündüz, John Paul Taylor, Julia Schumacher, Ian McKeith, Giovanni Frisoni, Angelo Antonini, Florinda Ferreri, Laura Bonanni, Maria Francesca De Pandis, Claudio Del Percio
Publikováno v:
SSRN Electronic Journal.
Autor:
Federico, Rodriguez-Porcel, Kathryn A, Wyman-Chick, Carla, Abdelnour Ruiz, Jon B, Toledo, Daniel, Ferreira, Prabitha, Urwyler, Rimona S, Weil, Joseph, Kane, Andrea, Pilotto, Arvid, Rongve, Bradley, Boeve, John-Paul, Taylor, Ian, McKeith, Dag, Aarsland, Simon J G, Lewis
Publikováno v:
Translational neurodegeneration. 11(1)
The selection of appropriate outcome measures is fundamental to the design of any successful clinical trial. Although dementia with Lewy bodies (DLB) is one of the most common neurodegenerative conditions, assessment of therapeutic benefit in clinica